Sept. 17, 2003 — Nanoxis AB, a Gothenburg, Sweden, nanobiotechnology company, announced that it secured $216,000 in funding.
Creandum KB, the Technology Link Foundation in Gothenburg (TBSG), The Holding Company at the University of Gothenburg (GU Holding AB) and AB Chalmerinvest participated in the round.
Nanoxis is developing protein chips for identifying certain proteins for drug development and the biotech industry. The company was spun off from Chalmers University of Technology in 2002.